Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

LncRNA SNHG16 promotes colorectal cancer cell proliferation, migration, and epithelial–mesenchymal transition through miR-124-3p/MCP-1

Subjects

Abstract

Colorectal cancer (CRC) has been the third leading cause of cancer-associated deaths. LncRNA SNHG16 is reported to be involved in metastasis of CRC cells. However, the mechanism by which SNHG16 regulates CRC progression is poorly understood. The proliferation of CRC cells was examined by MTT. Wound healing and transwell assay were used to measure migration and invasion ability. RT-qPCR and western blot were used to examine gene expression. Immunofluorescence was conducted to evaluate the EMT of CRC cells. Luciferase reporter assay were used to confirm direct interaction between miR-124-3p and SNHG16 or MCP-1. The interaction between miR-124-3p and SNHG16 was detected by RIP and RNA pull down assay. H&E staining was used to test the histomorphological changes of hepatic metastatic nodules. Finally, xenograft tumor experiment was utilized to determine tumor growth in vivo. SNHG16 and miR-124-3p were dysregulated in human colorectal tumors or cells. Knockdown of SNHG16 led to attenuate cell proliferation, migration, invasion, and EMT of CRC cells. And xenograft tumor experiment showed that SNHG16 might influence tumor growth. In contrast, miR-124-3p exerted the antitumor effects. Knockdown of miR-124-3p can reverse the effect of sh-SNHG16 on CRC cells. miR-124-3p could directly bind to SNHG16 or MCP-1. More importantly, MCP-1 acts as a critical effector mediating the role of SNHG16/ miR-124-3p in CRC cells. In summary, our data suggest that SNHG16 plays a contributory role in proliferation, migration, and EMT of CRC cells via miR-124-3p/MCP-1 axis, which offers a rationale for targeting SNHG16 and developing therapeutic drugs to treat CRC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: LncRNA SNHG16 is dysregulated in human colorectal tumors.
Fig. 2: Knockdown of SNHG16 attenuates proliferation, migration, invasion, and EMT of CRC cells.
Fig. 3: Knockdown of SNHG16 attenuates proliferation and metastasis of CRC cells in vivo.
Fig. 4: SNHG16 acts as a ceRNA of miR-124-3p to inhibit miR-124-3p expression and activity.
Fig. 5: miR-124-3p attenuates proliferation, migration, invasion, and EMT of CRC cells.
Fig. 6: Knockdown of miR-124-3p can reverse sh-SNHG16-triggered inhibition of proliferation, migration, invasion, and EMT of CRC cells.
Fig. 7: miR-124-3p directly targets MCP-1 and SNHG16/miR-124-3p regulates MCP-1 expression.

Similar content being viewed by others

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.

    Article  PubMed  Google Scholar 

  2. Han D, Wang M, Ma N, Xu Y, Jiang Y, Gao X. Long noncoding RNAs: novel players in colorectal cancer. Cancer Lett. 2015;361:13–21.

    Article  CAS  PubMed  Google Scholar 

  3. Tomida C, Aibara K, Yamagishi N, Yano C, Nagano H, Abe T, et al. The malignant progression effects of regorafenib in human colon cancer cells. J Med Invest. 2015;62:195–8.

    Article  PubMed  Google Scholar 

  4. Jarroux J, Morillon A, Pinskaya M. History, Discovery, and Classification of lncRNAs. Adv Exp Med Biol. 2017;1008:1–46.

    Article  CAS  PubMed  Google Scholar 

  5. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Molecular cell. 2011;43:904–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Li Y, Lu Y, Chen Y. Long non-coding RNA SNHG16 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer via sponging miR-200a-3p. Biosci Rep. 2019;39.

  7. Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 2006;25:6163–9.

    Article  CAS  PubMed  Google Scholar 

  8. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 2010;20:589–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Xi ZW, Xin SY, Zhou LQ, Yuan HX, Wang Q, Chen KX. Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer. World J Gastroenterol. 2015;21:5454–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Mestdagt M, Polette M, Buttice G, Noel A, Ueda A, Foidart JM, et al. Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells. Int J Cancer. 2006;118:35–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475:222–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Yoshidome H, Kohno H, Shida T, Kimura F, Shimizu H, Ohtsuka M, et al. Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases. Int J Oncol. 2009;34:923–30.

    Article  CAS  PubMed  Google Scholar 

  13. McClellan JL, Davis JM, Steiner JL, Enos RT, Jung SH, Carson JA, et al. Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1. Am J Physiol Gastrointest Liver Physiol. 2012;303:G1087–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhao L, Lim SY, Gordon-Weeks AN, Tapmeier TT, Im JH, Cao Y, et al. Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis. Hepatology. 2013;57:829–39.

    Article  CAS  PubMed  Google Scholar 

  15. Kawano S, Nakamachi Y. miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70:i88–91.

    Article  CAS  PubMed  Google Scholar 

  16. Christensen LL, True K, Hamilton MP, Nielsen MM, Damas ND, Damgaard CK, et al. SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism. Mol Oncol. 2016;10:1266–82.

    CAS  Google Scholar 

  17. Xu FF, Zha GQ, Wu YP, Cai WL, Ao J. Overexpressing lncRNA SNHG16 inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93. Onco Targets Ther. 2018;11:8855–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Cai C, Huo Q, Wang XL, Chen B, Yang QF. SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5. Biochem Bioph Res Co. 2017;485:272–8.

    Article  CAS  Google Scholar 

  19. Wang X, Kan J, Han J, Zhang W, Bai L, Wu H. LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-135a and Promotes JAK2/STAT3 Signal Pathway in Gastric Cancer. J Cancer. 2019;10:1013–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Lu YF, Cai XL, Li ZZ, Lv J, Xiang YA, Chen JJ, et al. LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-4518 and Up-Regulating PRMT5 Expression in Glioma. Cell Physiol Biochem. 2018;45:1975–85.

    Article  CAS  PubMed  Google Scholar 

  21. Zhang K, Chen J, Song HZ, Chen LB. SNHG16/miR-140-5p axis promotes esophagus cancer cell proliferation, migration and EMT formation through regulating ZEB1. Oncotarget. 2018;9:1028–40.

    Article  PubMed  Google Scholar 

  22. Furukawa S, Soeda S, Kiko Y, Suzuki O, Hashimoto Y, Watanabe T, et al. MCP-1 promotes invasion and adhesion of human ovarian cancer cells. Anticancer Res. 2013;33:4785–90.

    CAS  PubMed  Google Scholar 

  23. Yang C, Chen D, Huang K, Zhang H, Xu D, Tian Y, et al. The expression of chemokine MCP-1 in colorectal carcinoma and its relationship to the infiltration of macrophage. Chin German. J Clin Oncol. 2006;5:343–6.

    CAS  Google Scholar 

Download references

Funding

This work was supported by Hunan provincial Natural Scientific Foundation [grant number 2017JJ3177] and National Natural Scientific Foundation of China [grant number 81502114].

Author information

Authors and Affiliations

Authors

Contributions

Z-YC and YP: guarantor of integrity of the entire study; Z-YC: study concepts, study design, manuscript preparation; X-YW: definition of intellectual content; Y-MY: literature research, manuscript editing; HC: clinical studies; YP: experimental studies, manuscript review; LY: data acquisition; M-HW: data analysis; D-TJ: statistical analysis.

Corresponding authors

Correspondence to Zhi-Yuan Chen or Ya Peng.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, ZY., Wang, XY., Yang, YM. et al. LncRNA SNHG16 promotes colorectal cancer cell proliferation, migration, and epithelial–mesenchymal transition through miR-124-3p/MCP-1. Gene Ther 29, 193–205 (2022). https://doi.org/10.1038/s41434-020-0176-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41434-020-0176-2

This article is cited by

Search

Quick links